| Peter J Chen, MD | |
|
4 Plaza Dr Ste 403, Sewell, NJ 08080-2747 | |
| (856) 270-4020 | |
| Not Available |
| Full Name | Peter J Chen |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 4 Plaza Dr Ste 403, Sewell, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083646194 | NPI | - | NPPES |
| 001792014 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD066771L (Pennsylvania) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 25MA07445600 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooper University Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cooper Obstetrical Associates Pc | 2365349347 | 8 |
| Cooper Faculty Ob-gyn, Pc | 9931090214 | 23 |
News Archive
Horizon Pharma, Inc. a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases, today announced that it entered into an exclusive agreement with Grunenthal for the commercialization of DUEXIS in Latin America.
The U.N. Food and Agriculture Organization (FAO) on Monday issued an alert warning that "floods and heavy rains have significantly damaged whole areas of agricultural land across southern Africa and that the livelihood and food security of farmers and their families are at risk," the Associated Press reports (2/7).
Will extending telomeres lead to longer, healthier lives? Researchers have taken an important step toward answering this question by developing a new treatment used in the laboratory that extends telomeres.
While targeted cancer treatments have reduced side effects and improved efficacy, chemotherapy remains the backbone of combination therapies for many forms of cancer. Unfortunately, cancer patients may suffer from several side effects from chemotherapy, including infertility and a weakened defense system that makes them susceptible to life-threatening infections.
› Verified 6 days ago
| Entity Name | Cooper Obstetrical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194745976 PECOS PAC ID: 2365349347 Enrollment ID: O20031217000744 |
News Archive
Horizon Pharma, Inc. a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases, today announced that it entered into an exclusive agreement with Grunenthal for the commercialization of DUEXIS in Latin America.
The U.N. Food and Agriculture Organization (FAO) on Monday issued an alert warning that "floods and heavy rains have significantly damaged whole areas of agricultural land across southern Africa and that the livelihood and food security of farmers and their families are at risk," the Associated Press reports (2/7).
Will extending telomeres lead to longer, healthier lives? Researchers have taken an important step toward answering this question by developing a new treatment used in the laboratory that extends telomeres.
While targeted cancer treatments have reduced side effects and improved efficacy, chemotherapy remains the backbone of combination therapies for many forms of cancer. Unfortunately, cancer patients may suffer from several side effects from chemotherapy, including infertility and a weakened defense system that makes them susceptible to life-threatening infections.
› Verified 6 days ago
| Entity Name | Cooper Faculty Ob-gyn, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225058027 PECOS PAC ID: 9931090214 Enrollment ID: O20040324000874 |
News Archive
Horizon Pharma, Inc. a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases, today announced that it entered into an exclusive agreement with Grunenthal for the commercialization of DUEXIS in Latin America.
The U.N. Food and Agriculture Organization (FAO) on Monday issued an alert warning that "floods and heavy rains have significantly damaged whole areas of agricultural land across southern Africa and that the livelihood and food security of farmers and their families are at risk," the Associated Press reports (2/7).
Will extending telomeres lead to longer, healthier lives? Researchers have taken an important step toward answering this question by developing a new treatment used in the laboratory that extends telomeres.
While targeted cancer treatments have reduced side effects and improved efficacy, chemotherapy remains the backbone of combination therapies for many forms of cancer. Unfortunately, cancer patients may suffer from several side effects from chemotherapy, including infertility and a weakened defense system that makes them susceptible to life-threatening infections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter J Chen, MD 1 Federal St # 200, Camden, NJ 08103-1088 Ph: (856) 356-4924 | Peter J Chen, MD 4 Plaza Dr Ste 403, Sewell, NJ 08080-2747 Ph: (856) 270-4020 |
News Archive
Horizon Pharma, Inc. a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases, today announced that it entered into an exclusive agreement with Grunenthal for the commercialization of DUEXIS in Latin America.
The U.N. Food and Agriculture Organization (FAO) on Monday issued an alert warning that "floods and heavy rains have significantly damaged whole areas of agricultural land across southern Africa and that the livelihood and food security of farmers and their families are at risk," the Associated Press reports (2/7).
Will extending telomeres lead to longer, healthier lives? Researchers have taken an important step toward answering this question by developing a new treatment used in the laboratory that extends telomeres.
While targeted cancer treatments have reduced side effects and improved efficacy, chemotherapy remains the backbone of combination therapies for many forms of cancer. Unfortunately, cancer patients may suffer from several side effects from chemotherapy, including infertility and a weakened defense system that makes them susceptible to life-threatening infections.
› Verified 6 days ago
Joann Richichi, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 239 Hurffville Crosskeys Rd, Ste 250, Sewell, NJ 08080 Phone: 856-262-8300 Fax: 856-262-1635 | |
Sandra Lynn Leber, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 570 Egg Harbor Rd, Suite C-2, Sewell, NJ 08080 Phone: 856-218-8300 Fax: 856-589-9487 | |
Dr. Michele Tartaglia, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 405 Hurffville Crosskeys Rd Ste 202, Sewell, NJ 08080 Phone: 856-589-1414 Fax: 856-256-5772 | |
Dr. Susan Janeczek, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 405 Hurffville Crosskeys Rd, Suite 202, Sewell, NJ 08080 Phone: 856-589-1414 Fax: 856-256-5772 | |
Dr. Martin E. Kanoff, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Kings Way E, Ste D4, Sewell, NJ 08080 Phone: 856-232-0050 Fax: 856-232-0251 | |
Kenneth C. Covone, D.O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 445 Hurffville Crosskeys Rd Bldg A, Sewell, NJ 08080 Phone: 856-218-2312 Fax: 856-218-5726 |